BIT Life Science' 3rd Annual PepCon 2010-The Dedicated Event for Protein...

BIT Life Science' 3rd Annual PepCon 2010 - The Dedicated Event for Protein/Peptide Professionals

Theme: After Solution to the Machines of Life
Time: March 21-23, 2010  Venue: Beijing , China

Invitation Letter

Dear Friends and Colleges,

BIT Life Sciences is proud to announce that PepCon-2010 will be held during March 21-23, 2010 in Beijing , China . This international event will focus on the cutting edge peptide and protein researches with the theme of After a Solution for the Machines of Life . On behalf of the organizing committee, we cordially invite you to attend our conference and bring your most updated information to exchange exciting ideas and new achievements during the conference.

This conference will feature an outstanding experience both scientifically and socially. Also, the oriental culture makes Beijing a fascinating and pleasant place to congregate with old colleagues and new friends to share the most important aspects of many exciting and rapid advances in peptide and protein researches. PepCon-2010 will cover the basic protein science , proteins and diseases enable protein technologies such as human proteome technologies and cancer research, protein kinases as targets of small molecule drug discovery, protein biomarkers, protein analysis and quality control, protein engineering and production, and proteins as drugs-non-Antibody and non-vaccine protein therapeutics. The conference will take the form of presentations, workshops, round table conferences, exhibitions and posters. It is our hope to provide an alternative exciting event in Asia Pacific Rim that updates the current trend and business model for the peptide and protein professionals. A crucial aspect of our never ending endeavors is to find solutions to difficult scientific problems, and our ultimate goal is to support translation of scientific discovery into application or therapeutics.

PepCon-2010 is a dedicated event following the success of the 1st PepCon -2008 in Shenzhen , China and the 2nd PepCon -2009 in Seoul , South Korea , it has become an influential conference for Protein/Peptide Professionals accessing to latest breakthroughs and frontiers in Protein/Peptide Sciences and Technology along with the potential business opportunities. Through PepCon events, totally 400+ renowned speakers published their visualized achievements and share their excitement, passion, creativity and innovation by networking with 2000 people in protein and peptide society. The plenary speakers included Dr. Harold A. Scheraga, eminent leader in protein folding; Dr. Marc Wilkins, who has defined the concept of the proteome and coined the term; Dr. Young-Ki Paik, President of HUPO and AOHUPO, South Korea; Dr. Kyung-Soo Hahm, President of the Korean Peptide Protein Society, South Korea; Dr. Gregg B. Fields, Professor, University of Texas Health Science Center, President Elect of American Peptide Society (APS), USA; Dr. David K. Robinson, Vice President, Bioprocess R&D, Merck Research Laboratories, Merck & Co., Inc., USA and Dr. Thomas Li, Head of Asia Pacific Technology Management, Roche Diagnostics Asia Pacific Pte. Ltd., USA .

In addition, this major international event will be held in Beijing , a mega-modern and appealingly ancient city. After the conference, you are welcomed to join the Tech tour in Beijing and Xi’ an to experience the traditional Chinese culture, find the fascination of terra-cotta figures and enjoy the delicious food in China . Website: http://

Please feel free to contact me if you need further information. We look forward to having you to be part of the must-attend event in protein and peptide sciences in 2010.

Sincerely yours,

Xiaodan Mei, Ph.D.
Executive Chair of PepCon-2010

Renown Speaker

Dr. Gilbert Omenn, Professor, University of Michigan , Leader of Human Plasma Proteome Project (HPPP) , USA	Dr. A. Keith Dunker, Professor, Indiana University , Founder/Father of The Protein Trinity, USA	Dr. Kazutoshi Mori, Professor, Kyoto University , 2009 Canada Gairdner Award Recipient , Japan
Dr. Waleed Danho, Distinguished Research Leader, Hoffmann-LaRoche Inc., 2009 recipient of the Lifetime Achievement Award of NJ ACS ,USA	Dr. John W. Kozarich, Chairman and President of ActivX Biosciences, USA	Dr. Steven Bodovitz, Principal and Co-Founder, BioPerspectives , USA

Scientific Program

Opening Addresses
•  Executives of GO and NGO of Protein Science Organizations,
•  Governmental Regulatory Officers
•  Leading Scientists
•  Industrial Leaders in Therapeutic Protein Development

Keynote Forum
•  Market Potential Of Promising Drugs Under Development
•  Advances In Therapeutic Applications
•  Impact of Cutting-Edge Technologies in Protein Discovery and Development
•  Emerging Scientific Discoveries and Development
•  Current Protein/ Enzyme Industry Atlas and Global Trend
•  Market Impact And Post-Marketing Issues  

Symposium 1: Basic Protein Science
Session 1-1: Advances of Protein Molecular Biology and Cell Biology
Session 1-2: Protein Folding Dynamics, Stability and Quality Control
Session 1-3: Protein-Protein Interactions and Protein-Transduction
Session 1-4: Proteins Interacting with DNA and RNA
Session 1-5: Structure Biology, Protein Structure, Dynamics and Functions
Session 1-6: Membrane Proteins
Session 1-7: Proteins and Signaling
Session 1-8: Protein Trafficking/ Transport/ Translocation , Assembly
Session 1-9: Ubiquitin, Protein Conjugation and Degradation
Session 1-10: Protein Metabolism, Secretion, and Enzyme Dynamics
Session 1-11: Protein Splicing and Endo -and Exocytosis
Session 1-12: Protein Modifications
Session 1-13: Green Fluorescent Protein

Symposium 2: Protein Technologies
Session 2-1: Protein Screening, Bioassay and Discovery
Session 2-2: NMR, EM and X-Ray Crystallography
Session 2-3: Protein Chips, Arrays and Protein Structures in Silico
Session 2-4: Cell Free Technologies for Proteins
Session 2-5: Robust Microscale and Nanoscale Separation/Purification Technologies

Symposium 3: Proteins and Diseases
Session 3-1: Protein Interactions and Diseases
Session 3-2: Protein Networks in Disease
Session 3-3: Proteins in Apoptosis and Autophagy
Session 3-4: Protein Misfolding and Cancers
Session 3-5: Protein Misfolding and Neurodegeneration
Session 3-6: Protein Therapeutics for Immunologic & Inflammatory Diseases

Symposium 4: Human Proteome Technologies and Cancer Research
Session 4-1: MS, Imaging MS and MALDI-TOF in Proteomics
Session 4-2: Gel/Non-Gel Technologies, and Capillary Electrophoresis Systems in Proteomics
Session 4-3: Computational Proteomics and Bioinformatics
Session 4-4: Nanoproteomics, Chip and Array Technologies in Proteomics
Session 4-5: Protein Profiling and Interactome in Proteomics
Session 4-6: System Biology and Omics Network
Session 4-7: Clinical Proteomics
Session 4-8: Proteomics of Brain, Neck and Head Tumors
Session 4-9: Proteomics of Breast Cancer
Session 4-10: Proteomics of Colorectal and Colon Cancer
Session 4-11: Proteomics of Lung Cancer
Session 4-12: Proteomics of Esophageal Cancer
Session 4-13: Proteomics of Hepatic and Pancreatic Cancer
Session 4-14: Proteomics of Leukemia
Session 4-15: Proteomics of Prostate Cancer
Session 4-16: Proteomics of Ovarian and Cervical Cancer

Symposium 5: Protein Kinases as Targets of Small Molecule Drug Discovery
Session 5-1: Protein Kinases and Kinome as Drug Targets-Preclinical to Clinical Trials
Session 5-2: Protein Kinase and Apoptosis
Session 5-3: Protein Kinase Inhibitors in Cancer
Session 5-4: Protein Kinase and Cell Cycle Control
Session 5-5: Receptor Tyrosine Kinases
Session 5-6:The ErbB Family and Associated Signaling
Session 5-7: SER/THR Kinases
Session 5-8: The AKT/PI 3-Kinases, and The MAP Kinase Pathway
Session 5-9: Sugar Kinases and Lipid Kinases
Session 5-10: Kit/Notch/Wnt Signaling Pathways
Session 5-11: Kinase Screening, Profiling, Identification and Lead Optimization
Session 5-12: Kinases of Toxicological Concern
Session 5-13: Small Molecule Kinase Inhibitor Discovery

Symposium 6: Other Protein Based Drug Discovery
Session 6-1: Target Discovery and Validations
Session 6-2: GPCRs in Drug Discovery
Session 6-3: Protein Structure, Modeling, and Fragment-Based Drug Discovery
Session 6-4: Protein Crystallography in Drug Discovery
Session 6-5: Protein Drug Delivery System and Nanotechnologies
Session 6-6: Design Drugs Targeting Protein-Protein Interactions
Session 6-7: New Peptides Drug Discovery  

Symposium 7: Protein Expression
Session 7-1: Advances in Control of Gene Expression and Alternative Expression
Session 7-2: Eukaryotic/ Prokaryotic, Insect and Mammalian Expression
Session7-3: Downstream Protein Expression Technologies
Session 7-4: Novel Protein Expression Systems and Sample Purification, Detection Technologies
Session 7-5: High Throughput Protein Production and Gene Expression Analysis
Session 7-6: Novel and Emerging Hosts for Difficult-to-Expression Proteins

Symposium 8: Protein Biomarkers
Session 8-1: Protein Biomarker Discovery and Validation for Diagnosis and Treatment
Session 8-2: Toxicity Biomarkers and Biomarkers Assay Development
Session 8-3: Protein Biomarkers for Cancers
Session 8-4: Biomarkers in Drug Development and Clinical Use
Session 8-5: Protein Biomarkers for Diseases: Cardiovascular, CNS, Inflammation and Immunology
Session 8-6: Biomarker for Personalized Medicine

Symposium 9: Protein as Biocatalysts and Biomaterials
Session 9-1: Protein Design and Evolution for Enzymes
Session 9-2: Metabolic Pathway Engineering and Systems Biology
Session 9-3: Extremophilic Enzyme Discovery and Development
Session 9-4: Protein Biomaterial Design and Implications
Session 9-5: Case Studies on Novel Economical Industrial Enzymes

Symposium 10: Protein Analysis and Quality Control
Session 10-1: Progress of Analytical Techniques for Protein
Session 10-2: Chip and Array Technology for Protein Analysis
Session 10-3: HPLC, LC-MS and SFC in Protein Analysis
Session 10-4: Spectroscopic Analysis and other GMP Compliance Analytical Methods
Session 10-5: Novel Machines, Tools, Software, Instruments and Equipment for Protein Analysis

Symposium 11: Protein Engineering and Production
Session 11-1: Cellular Engineering and New Host System Development
Session 11-2: Cell Line and Cell Culture Development & Upstream Processing
Session 11-3: Improved Separation, Purification, Recovery, Crystallization, and Lyophilization
Session 11-4: Scaling Up Bioprocess Development for Biotherapeutics
Session 11-5: New Protein Therapeutic Formulation Development

Symposium 12: Proteins as Drugs-Non-Antibody and Non-Vaccine Protein Therapeutics Session 12-1: Cytokines /Chemokine, Interleukins
Session 12-2: Antithrombins and Blood Clotting Factors
Session 12-3: Human Growth Hormones
Session 12-4: Hematopoietics and Blood Modifiers
Session 12-5: Insulin and Insulin Like Proteins
Session 12-6: Plasma Proteins
Session 12-7: Enzymes
Session 12-8: Interferons
Session 12-9: Colony and Follicle Stimulating Hormone Factors
Session 11-10: Growth Factors

Website: http://

Exhibition in PepCon 2010

This conference is essential for all researchers and professionals involved in the protein/peptide area. We offer various opportunities for your company to maximize its exposure and influence. The delegates of our conferences are the true decision makers from relevant companies, organizations or institutes. Our conference provides a great opportunity to network perform, product demonstrations and to create brand awareness.

Exhibitor Benefits include:
· One Booth Space in the Main Conference Networking Area
· Logo on PepCon Website with Direct Link to Your Website
· Logo on Direct Mail Brochure Distributed to over 100,000 Potential Attendees
· Face-To-Face Marketing your Solutions, Technologies or Products to over 500 Attendees
· Insert in the Conference Tote Bag
· One Registration with Full Conference Access
· One "Booth Only" Personnel Registration
· Participation in Comprehensive Pre-event Marketing Campaigns
· Meeting Guide, Proceeding & Conference Directory Company Listing Including Contact Information and 100 words Description
· Tailored Marketing Strategies to Suit Your Organization’s Size, Capabilities and Individual Requirement
· Discount for Your Customers

Who Should Exhibit?
· Peptide Synthesis
· Outsourcing Services
· Antibody Engineering
· Vaccine
· Bioinformatics
· Bioprocessing
· Drug Discovery
· Biomarkers
· Diagnostics
· Protein Chips and Microarrays
· Protein Characterization
· Protein Therapeutics
· Enzyme Engineering
· Scale-Up & High-throughput
· Purification & Sequencing
· Expression Vectors
· Protein Drug Delivery
· Immunogenicity
· Assay Development
· Disease Prognosis
· Protein-Protein Interactions

Contact Us:
Ms. Sally Guo,
Program Coordinator
Organizing Committee of PepCon-2010
26 Gaoneng St. , F4
Dalian Hightech Zone
Dalian , LN 116025, China
Tel: 0086-411-84799609 ext. 801
Fax: 0086-411-84799629
Email: sally@
Website: http://